U.S. dental merger and acquisition activity is accelerating again after a prolonged slowdown, with more than 175 practice locations changing hands in the first half of 2026 alone. As of October 2026, roughly 35% of the U.S. dental industry is now consolidated under dental support organizations (DSOs) and private equity-backed platforms. Canadian practice owners watching from across the border should pay close attention — the consolidation playbook that reshaped American dentistry is already making inroads here.
The numbers tell a clear story. According to a mid-year analysis published by Oral Health Group, more than 175 practice locations were sold to DSOs, private equity groups, and other buyers during the first six months of 2026. The actual figure is likely higher, the report notes, because industry benchmarks typically lag completed transactions by several months. This marks a meaningful rebound from the deal slowdown that characterized 2024 and early 2025, when elevated interest rates and persistent inflation cooled buyer enthusiasm across the healthcare M&A landscape.
What Is Driving the Rebound
Several forces are converging to restart the deal machine. First, interest rate stabilization has made leveraged buyouts more predictable for private equity sponsors. Second, larger DSO platforms that recapitalized during the slowdown are now deploying that capital into new acquisitions. According to Oral Health Group, 78% of buyers surveyed expect to complete recapitalization within 12 to 36 months, creating a defined window of acquisition activity.
Third, the generational math is shifting. The associate-to-owner pipeline that sustained independent practice for generations is thinning as new graduates weigh student debt loads against the overhead of a solo start-up. Private equity affiliation among U.S. dentists nearly doubled from 6.6% in 2015 to 12.8% in 2021, according to Oral Health Group, and DSO affiliation reached 16.1% by 2024.
Practice Valuations Remain Elevated — For Now
Sellers in today's market are still commanding strong multiples. Current dental practice valuations range from five to nine-plus times EBITDA, according to Oral Health Group, with DSOs typically paying 60% to 85% or more in cash at closing. The long-term forecast, however, points to a normalization in the range of four to six times EBITDA as the industry matures and buyer competition stabilizes.
Kevin Cumbus, founder of TUSK Practice Sales, noted in the report that movement among larger dental companies is creating a "seller's window" for financially healthy practices. The implication is clear: practice owners who have been contemplating an exit may find the current cycle more favourable than what comes next.
The Reimbursement Squeeze Behind the Deals
A less visible but equally important factor is the growing gap between dental reimbursement rates and practice operating costs. According to the Oral Health Group analysis, dental reimbursement rates increased 19% between January 2021 and June 2026, while general inflation rose 27% over the same period. That eight-percentage-point gap represents real margin erosion for practice owners — and it gives DSOs a structural advantage, since their centralized procurement, staffing, and administrative systems can absorb cost increases that overwhelm a solo practitioner.
Pro Tip: If you are a Canadian practice owner evaluating whether to sell, request a practice valuation from a qualified dental-specific broker before an unsolicited offer arrives. Knowing your EBITDA multiple in advance gives you leverage in any negotiation.
What This Means for Canadian Dental Practices
Canada's dental market is following a similar trajectory, though the consolidation curve is years behind the American one. Several DSO-backed groups have expanded their Canadian footprint in recent years, and private equity interest in Canadian dental practices continues to grow. Ontario, British Columbia, and Alberta have seen the most activity.
For Canadian practice owners, the U.S. data offers several practical takeaways:
- Valuations are cyclical. The current five-to-nine-times-EBITDA range in the U.S. will not last indefinitely. Canadian practice owners near retirement should assess their timeline against the maturation curve rather than assuming today's premiums will persist.
- New graduates are increasingly DSO-bound. With U.S. DSO affiliation rising steadily — from 6.6% private equity affiliation in 2015 to 16.1% DSO affiliation by 2024 — the pool of potential practice buyers who want to own independently is narrowing. The same dynamic is emerging in Canada as dental school debt loads rise.
- Margin compression favours scale. The 19%-vs-27% reimbursement-inflation gap in the U.S. mirrors the cost pressures Canadian practices face under provincial fee guide increases that lag real overhead growth. Practices that cannot achieve procurement and staffing efficiencies may find the economics of independence increasingly difficult.
- Due diligence matters more than ever. As deal structures become more complex — with earn-outs, equity rollovers, and non-compete provisions — practice owners need legal and financial advisors who specialize in dental transactions, not general small-business M&A.
Pro Tip: Before signing any letter of intent with a DSO or private equity buyer, have an independent dental practice accountant review the proposed EBITDA calculation. Buyers often use adjusted EBITDA that adds back owner compensation and discretionary expenses, which can inflate the headline number.
The Independent Practice Path Forward
Consolidation does not mean the end of independent dentistry. Practices that invest in operational efficiency, build strong patient retention systems, and maintain healthy margins can thrive outside the DSO model. The Canadian Dental Association (CDA) and the Ontario Dental Association (ODA) both offer practice management resources designed to help independent practitioners compete effectively.
The question for every Canadian practice owner is not whether consolidation is coming — it is already here. The question is whether your practice is positioned to choose its own path, whether that means a well-timed sale at a favourable multiple or a deliberate decision to remain independent with the systems to support that choice.
Frequently Asked Questions
Q: How many dental practices were sold to DSOs in the first half of 2026?
According to Oral Health Group, more than 175 U.S. dental practice locations were sold to DSOs, private equity groups, and other buyers in H1 2026. The actual number is likely higher because industry benchmarks typically lag completed transactions.
Q: What are dental practice valuations in 2026?
Current U.S. dental practice valuations range from five to nine-plus times EBITDA, with DSOs typically paying 60% to 85% or more in cash at closing. Long-term forecasts suggest valuations will normalize to four to six times EBITDA as the market matures.
Q: Is dental consolidation happening in Canada?
Yes. While Canada's dental market is less consolidated than the U.S. (which stands at approximately 35%), several DSO-backed groups have expanded their Canadian presence in Ontario, British Columbia, and Alberta. Canadian practice owners face similar cost pressures and generational shifts that are driving U.S. consolidation.